[cobras]

Ależ skąd. Na odwrót. To poziom artykułów buduje reputację pisma. Opublikowanie jakiejś kompletnej bzdury w "Nature" nie nobilitowałoby tej bzdury, za to obniżyłoby prestiż "Nature".

No nie, opublikowanie gównobadań Wakefieldaa w Lancecie wcale nie pomogło rozpętać całej tej antyszczepionkowej histerii.


A tymczasem w USA:
https://www.thenation.com/article/alex-a...-diabetes/

At T1International we asked people with type 1 diabetes around the world how much they paid each month to stay alive. The United States topped every country, spending on average $571.69 per month on diabetes costs. Even with insurance, some Americans are spending around half their income on insulin and other supplies.

n fact, price gouging from Eli Lilly and other insulin manufacturers has already had deadly consequences. Shane Patrick Boyle, a founder of Zine Fest Houston, died on March 18 after his GoFundMe campaign to pay for insulin came up $50 short. Alec Raeshawn Smith, age 26, was found dead in his apartment on June 27. He was rationing his insulin after he aged out of his parent’s insurance coverage. The sad fact is more people would be alive today if insulin was affordable for all Americans.

Contrary to pharma propaganda, insulin is neither “new” nor “innovative.” It was developed in Toronto in 1921. The discoverers turned down the chance to create for-profit clinics. Instead, they licensed their creation for $1 (Canadian) a piece. Their recorded reason for doing this was to make sure insulin would be available for all who needed it. Eli Lilly’s was tasked with manufacturing insulin for North America. There was an understanding insulin would be sold at a reasonable price until there was a cure for diabetes.

Wolny rynek w służbie zdrowia taki zajebisty.